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A B S T R A C T
Background: Recently, the value of various structural body components have been proposed for
predicting cardio-metabolic risk. The present study aimed to assess the wrist circumference (WrC) as an
alternative measure for differentiating patients with CAD and METs from those without CAD and METs.
Methods: We studied 228 consecutive subjects who underwent coronary angiography. Those with and
without evidence of coronary artery involvement at angiography were considered as the coronary artery
disease (CAD) group (n = 139) and the non-CAD group (n = 89), respectively. WrC was measured; and
metabolic syndrome (METs) was deﬁned according to the modiﬁed National Cholesterol Education
Program Adult Treatment Panel III criteria.
Results: WrC was signiﬁcantly higher in CAD compared to non-CAD patients (17.85  1.29 mm vs
17.43  1.29 mm, P = 0.017). The overall prevalence of METs was signiﬁcantly different between the CAD and
non-CAD subjects (74.3% vs 58.8%, P = 0.016). Although there was a tendency for association, no statistically
signiﬁcant association between the mean of the WrC and the severity of CAD was found (P = 0.065). WrC had
a weak positive correlation with triglyceride (r = 0.172, P = 0.011) and cholesterol (r = 0.141, P = 0.038) level
and a weak negative association with high-density lipoprotein level (r = 0.279, P < 0.001). In multivariate
logistic regression models, WrC could predict neither presence of CAD nor METs.
Conclusion: Although correlated with METs-type lipid proﬁle, WrC may not be a valuable index for
predicting the presence of CAD or METs.
 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Cardiovascular diseases (CVDs) are now clearly identiﬁed as a
major cause of mortality worldwide at both developed and
developing countries.1,2 Because of the multifactorial risk proﬁle
of CVDs, reducing the incidence of those diseases has been a
fundamental problem of healthcare systems in each community.3,4
Whereas preventive programs in developed countries resulted in
downward trend of CVDs over the past decade,5,6 lack of such
programs made the CVDs even more prevalent in low-income
countries during the recent years.7,8 Therefore, nowadays, early
diagnosis and control of cardiovascular risk factors is more
essential among developing communities.* Corresponding author at: Rasoul-e-Akram Medical Center, Niyayesh Street,
Sattarkhan Ave., Tehran, Iran.
E-mail address: Morteza_hb@yahoo.com (M. Hassanzadeh).
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creativecommons.org/licenses/by-nc-nd/4.0/).Of various potential risk factors for CVDs, the role of
anthropometric and metabolic indicators, with some causal and
synergistic effects,9 is obvious. On epidemiologic studies, it has
been clearly found that obesity has a role to develop insulin
resistance, diabetes, and metabolic syndrome (METs).10 In fact, a
cluster of anthropometric parameters are proposed as obesity-
equivalent for identifying individuals with higher risk for CVDs.
Initially, body weight and body mass index (BMI) were identiﬁed
as main indicators for obesity; but those indices could not
speciﬁcally distinguish fat from muscle mass, nor represent the
distribution pattern of one’s body fat.11,12 Therefore, some other
anthropometric parameters such as increased waist circumference
and waist to hip ratio have been proposed and have been
demonstrated to be closely associated with higher cardiovascular
risk.12,13 The values of these parameters, however, are signiﬁcantly
affected by various environmental and hereditary factors, making
their speciﬁcity lowered for cardiovascular risk estimation.14 Also,
it is practically difﬁcult to get the accurate measurement of suchrist circumference for predicting the presence of coronary artery
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different sites of measurements.15
Recently, some other structural components of the body have
been introduced for predicting cardio-metabolic risk. In some
studies, increased neck or wrist circumference (WrC) could well
discriminate high-risk groups with morbid obesity, diabetes
mellitus, dyslipidemia, or METs.16,17 In a pathophysiologic point
of view, increased bone mass has been proved to be associated
with hyperinsulinemia18; and the insulin receptor signaling
pathway has been demonstrated to communicate the bone
remodeling process with the body metabolic control.19 Therefore,
WrC in this context could be considered as an indirect determinant
of hyperinsulinemia and insulin resistance. Assuming there is no
comprehensive data in the literature focusing on the eligibility of
WrC as a potential risk indicator for CVD, the present study aimed
to assess the WrC as an alternative tool for differentiating patients
with CAD and METs from those without CAD and METs.
2. Materials and methods
2.1. Study population
This case control association study was conducted on consecu-
tive patients aged >30 years who were underwent coronary
angiography at Shahid Rajaei Heart Center, Tehran, Iran during
2014. Among participants, those with evidence of meaningful
coronary involvement in angiography (50% stenosis) were
considered as the coronary artery disease (CAD) group and others
without any evidences of signiﬁcant coronary stenosis were
considered as the non-CAD group. Those with previous history of
CVDs or cardiovascular diagnostic or therapeutic interventions
were all excluded. Also, those with the history of upper
extremities’ major trauma, fractures or deformities, acquired or
inherited skeletal disorders, stroke, or malignancy were excluded
from the study. The study protocol was approved by the Research
Ethics Committee of the Iran University of Medical Sciences, and
signed informed consents were collected from all participants. All
authors agreed on adherence to the Helsinki Declaration.
2.2. Study measurements
Baseline demographic characteristics, cardiovascular risk fac-
tors, and medications were collected by interviewing, physical
examination, and lab tests. In this regard, hypertension was
deﬁned as concurrent use of antihypertensive agents or systolic
blood pressure (SBP)  140 mmHg or diastolic blood pressure
(DBP)  90 mmHg; obesity was deﬁned according to the World
Health Organization deﬁnition as a BMI  30 kg/m2; diabetes
mellitus was diagnosed either from concurrent use of oral
hypoglycemic agents or insulin, or if fasting blood sugar (FBS)
was 126 mg/dl; current smoking history was deﬁned as regular
smoking a tobacco product, or a smoking history during the
30 days prior to admission; and hyperlipidemia was deﬁned as a
total cholesterol  200 mg/dl, high-density lipoprotein cholesterol
(HDL-C)  40 mg/dl (men) or 50 mg/dl (women), and triglycer-
ides  150 mg/dl. To assess anthropometric parameters, body
weight was measured by Seca scales (Germany) with minimal
clothing and no shoes (recorded as rounded to the nearest 100 g);
height was measured in a standing position, without shoes while
the shoulders were in a normal position (recorded as rounded to
the nearest 0.5 cm); waist circumference was measured at top of
iliac crest in mid axillary line without applying any pressure
(recorded as rounded to the nearest 0.1 cm); BMI was estimated as
weight (kg) divided by height (m) squared; waist to hip ratio was
measured as waist circumference (cm) divided by height (cm); and
WrC was measured using an un-stretchable tape measurePlease cite this article in press as: Hajsadeghi S, et al. The value of w
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the distal of ulna when subjects were in a sitting position. All
measurements were performed by a single person to minimize
inter-observer variability.
METs was deﬁned according to the modiﬁed National
Cholesterol Education Program Adult Treatment Panel III criteria
as the presence of at least 3 of the followings:
1) waist circumferences  90 cm for men and 80 cm for women
2) SBP  130 mmHg or DBP  85 mmHg
3) serum triglyceride level  150 mg/dl
4) HDL-C 50 mg/dl and 40 mg/dl for women and men,
respectively
5) FBS  100 mg/dl
A qualiﬁed physician measured blood pressure two times in a
sitting position after 15 min of rest using a standard mercury
sphygmomanometer; and the mean of the two measurements was
recorded as the participant’s blood pressure. To measure
laboratory parameters, blood samples were obtained in the early
morning after an overnight fast at the subject’s home. Samples
were assayed for FBS, total cholesterol, low-density lipoprotein
cholesterol (LDL-C), and HDL-C using standard techniques on a
Cobas autoanalyzer system.
2.3. Statistical analysis
Results were presented as mean  standard deviation (SD) for
quantitative variables and were summarized by frequency (percent-
age) for categorical variables. Continuous variables were compared
using t test or Mann–Whitney U test whenever the data did not
appear to have normal distribution or when the assumption of equal
variances was violated across the study groups. Categorical variables
were, on the other hand, compared using Chi-square test.
The multivariate logistic regression analysis model was used to
assess the difference in WrC between CAD and non-CAD groups
with the presence of confounders. Namely, the presence of CAD
was considered as the dependent variable, wrist circumference as
the independent variable, and the baseline parameters including
gender, age, family history for CAD, current smoking, history of
diabetes mellitus, METs, high SBP and/or DBP measurements, lipid
proﬁles (triglyceride, cholesterol, LDL-C, HDL-C), and serum uric
acid level as the potential confounders. In such model, we included
13 baseline variables as the independents to assess the association
between WrC and CAD. In other word, with the suspicion to
potential confounding impact of gender, advanced age, cardiovas-
cular risk factors and laboratory indices, all of these parameters
were included into the model for adjusting.
To determine the value of anthropometric indices to discrimi-
nate CAD from non-CAD and also METs from non-METs conditions,
the receiver-operating characteristic (ROC) curve was analyzed
deﬁning a value >0.80 as good discriminative value. For the
statistical analysis, the statistical software SPSS version 16.0 for
windows (SPSS Inc., Chicago, IL) was used. P values of 0.05 or less
were considered as statistically signiﬁcant.
3. Results
By strict consideration of the exclusion criteria, no subjects
were secondarily excluded after ﬁrst being included; and a total of
228 subjects were recruited to this study, 139 of whom were
categorized as CAD and 89 as non-CAD. Comparing the two groups
(Table 1), those with CAD showed higher male gender frequency,
higher mean age, as well as higher prevalence of diabetes mellitus
and METs. Also, the mean level of FBS and SBP were signiﬁcantlyrist circumference for predicting the presence of coronary artery
i.org/10.1016/j.ihj.2016.10.011
Table 1
Baseline characteristics in coronary artery disease (CAD) and non-CAD groups.c
Item None CAD group
(n = 89)
CAD group
(n = 139)
P-value
Male gendera 45 (51) 101 (73) 0.001
Age, yearb 53  11 61  1 <0.001
Family history for CADa 23 (26) 43 (31) 0.408
Current smokinga 16 (18) 37 (27) 0.132
Diabetes mellitusa 21 (24) 56 (40) 0.009
Metabolic syndromea 50 (59) 101 (74) 0.016
SBP (mmHg)b 127  17 135  22 0.003
DBP (mmHg)b 76  10 76  10 0.985
BMI (kg/m2)b 27.8  5.4 28.2  4.9 0.623
Waist to hip ratiob 0.58  0.09 0.59  0.08 0.405
Waist circumference (cm)b 95  15 97  11 0.178
Wrist circumferences (mm)b 17  1 18  1 0.017
Serum triglyceride (mg/dl)b 107 (85, 172) 130 (91, 192) 0.218
Serum cholesterol (mg/dl)b 158 (133, 178) 146 (125, 174) 0.075
Serum LDL (mg/dl)b 92 (73.5, 108) 85 (71, 103) 0.157
Serum HDL (mg/dl)b 36 (35, 42) 36 (33, 38) 0.029
Serum uric acid (mg/dl)b 5.2  1.5 5.4  1.4 0.461
FBS (mg/dl)b 93 (85, 108) 110 (94, 152) <0.001
a Values are number (%).
b Values are mean  standard deviation, or median (interquartile range) where appropriate.
c SBP: systolic blood pressure, DBP: diastolic blood pressure, BMI: body mass index, LDL: low-density lipoprotein, HDL:
high-density lipoprotein, FBS: fasting blood sugar.
Table 2
Correlation between anthropometric indices and risk factors of coronary artery
disease.a
Item R coefﬁcient P value
Age 0.056 0.405
BMI 0.363 <0.001
Metabolic syndrome score 0.207 0.002
SBP 0.013 0.851
DBP 0.102 0.125
Serum triglyceride 0.172 0.011
Serum cholesterol 0.141 0.038
Serum LDL 0.128 0.060
Serum HDL 0.279 <0.001
Serum uric acid 0.033 0.635
FBS 0.066 0.333
a BMI: body mass index, SBP: systolic blood pressure, DBP: diastolic blood
pressure, LDL: low-density lipoprotein, HDL: high-density lipoprotein, FBS: fasting
blood sugar.
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signiﬁcantly different between the CAD and non-CAD groups
(74.3% vs 58.8%, P = 0.016). Of anthropometric indices, only the
mean  SD for WrC was signiﬁcantly higher in CAD compared toTable 3
Main predictors of coronary artery disease (CAD) in multivariable logistic regression m
Factor B SE Wald 
Wrist diameter .144 .165 .754 
Male gender 1.027 .466 4.852 
Age .063 .017 13.080 
Family history of CAD .410 .402 1.040 
Smoking .575 .448 1.649 
Diabetes mellitus .433 .446 .942 
SBP .027 .011 5.852 
DBP .003 .020 .029 
Serum triglyceride .001 .003 .069 
Serum cholesterol .004 .006 .484 
Serum LDL .009 .028 .103 
Serum HDL .053 .125 .180 
Serum uric acid .003 .005 .576 
Hosmer and Lemeshow goodness of ﬁt: Chi-square = 17.274, P = 0.027.
a SBP: systolic blood pressure, DBP: diastolic blood pressure, LDL: low-density lipop
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Considering the achieved mean (SD) of WrC in the individuals with
normal coronary status as 17.43 (1.29) mm, in patients with single-
vessel disease as 17.79 (1.33) mm, in patients with 2-vessel disease as
17.92 (1.41) mm, and in those with 3-vessel disease as 17.93 (1.18)
mm, there was no statistically signiﬁcant association between the
mean WrC and the severity of CAD (P = 0.065). As shown in Table 2,
the value of WrC found to have a weakly positive correlation with the
METs score (r = 0.207, P = 0.002), serum triglyceride (r = 0.172,
P = 0.011), and serum cholesterol level (r = 0.141, P = 0.038); and a
weakly negative correlation with serum HDL-C level (r = 0.279,
P < 0.001).
On multivariable logistic regression model (Table 3), the
main determinants of CAD included male gender, advanced
age, and higher SBP; while higher WrC could not predict the
presence of CAD. In similar multivariate regression model
(Table 4), it was shown that the value of WrC could not predict
presence of METs. Using the ROC curve analysis (Figs. 1 and 2),
none of the anthropometric indices, including wrist diameter,
waist circumference, waist to hip ratio and BMI, could
discriminate CAD from non-CAD (Fig. 1) or METs from non-
METs subjects (Fig. 2).odel.a
P-value OR 95.0% CI for OR
Lower Upper
.385 1.155 .835 1.597
.028 2.793 1.120 6.967
.000 1.065 1.029 1.102
.308 1.507 .685 3.313
.199 1.777 .739 4.274
.332 1.542 .643 3.693
.016 1.028 1.005 1.050
.864 .997 .958 1.037
.793 1.001 .996 1.006
.487 .996 .984 1.008
.748 .991 .937 1.048
.671 1.055 .825 1.349
.448 1.003 .995 1.012
rotein, HDL: high-density lipoprotein.
rist circumference for predicting the presence of coronary artery
i.org/10.1016/j.ihj.2016.10.011
Table 4
Main predictors of metabolic syndrome in multivariable logistic regression model.b
Factor B SE Wald P-value OR 95.0% CI for OR
Lower Upper
Wrist diameter .068 .259 .069 .792 1.071 .644 1.780
Male gender 1.770 .780 5.146 .023 .170 .037 .786
Age .032 .025 1.577 .209 1.032 .982 1.084
Family history for coronary artery disease .479 .560 .732 .392 .620 .207 1.856
Smoking .586 .690 .722 .395 1.797 .465 6.942
Diabetes mellitus .495 .666 .553 .457 .609 .165 2.248
SBP .090 .022 16.204 .000 1.094 1.047 1.143
DBP .026 .032 .635 .425 1.026 .963 1.093
Serum triglyceride .046 .010 19.618 .000 1.047 1.026 1.068
Serum cholesterol .022 .011 4.009 .045 .978 .957 1.000
Serum LDL .079 .043 3.379 .066 .924 .849 1.005
Serum HDL .196 .187 1.105 .293 .822 .570 1.185
Serum uric acid .036 .011 10.859 .001 1.036 1.015 1.059
a Hosmer and Lemeshow goodness of ﬁt: Chi-square = 16.038, P = 0.042.
b SBP: systolic blood pressure, DBP: diastolic blood pressure, LDL: low-density lipoprotein, HDL: high-density lipoprotein.
Fig. 1. The receiver-operating characteristic analysis curve to determine value of
anthropometric indices to discriminate CAD from non-CAD status (the area under
the curve for wrist diameter, waist diameter, body mass index, and waist to hip ratio
are 0.615, 0.531, 0.505, and 0.522 respectively).
Fig. 2. The receiver-operating characteristic analysis curve to determine the value of
anthropometric indices for discriminating metabolic syndrome (METs) from non-
METs status (the area under the curve for wrist diameter, waist diameter, body
mass index, and waist to hip ratio are 0.607, 0.755, 0.689, and 0.748 respectively).
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Anthropometric parameters have been well proved as decisive
measures related to cardio-metabolic risk in large cohort studies
such as the well-known Framingham survey20 and the World
Health Organization guidelines.21 In this regard, increased BMI,
increased waist circumference, and increased waist to hip ratio
have all been shown to be associated with increased risk for both
CAD and METs. However, in this study, those parameters were not
different among CAD and non-CAD groups, nor could discriminate
CAD subjects. One explanation might be our ‘point’ measurement
of those indices rather than measuring them during a time course.
Moreover, the role of such parameters is best considered in the
context of other known risk factors as a whole rather than in parts.
Some recent evidences have been focused on the usefulness of
measuring WrC for predicting risk of CVDs.22,23 In fact, these
evidences emphasize more on association between WrC and
metabolic risk subgroups such as obesity, insulin resistance, and
METs; and the independent role of WrC in predicting CAD risk has
not been clearly determined. The present study attempted to
examine whether more WrC might predict higher risk for CAD and
METs. At the ﬁrst step and univariately, those with CAD were
shown to have more WrC. However, using multivariate regression
modeling or by ROC curve analysis, that univariate relationship
was not proved as predictive. Besides, we could ﬁnd signiﬁcant
association between WrC and patients’ atherosclerotic lipid
proﬁle; namely higher triglyceride and cholesterol, and lower
HDL-C level. Therefore, the relationship between the presence of
CAD and higher WrC might be indirectly mediated by higher levels
of triglyceride and cholesterol and lower levels of HDL-explaining
non-signiﬁcant weight of WrC for predicting CAD while being
slightly associated with the severity of CAD. Additionally, as
another description for why WrC was not found to be a predictor of
CAD, we may have involved lower risk CAD patients (with lower
Framingham risk scores) in our study; and a good issue for future
studies could be looking for the possible role of WrC among higher
risk patients with CAD.
On the other hand, according to the recent literature, it has been
demonstrated by Tatar BT24 that WrC is positively correlated with
the level of insulin resistance, weight, and BMI, as well as neck,
waist and hip circumferences, and waist to hip ratio; but
negatively correlated with HDL-C level. Similar associations have
also been indicated among Iranian CAD patients in a study by
Amini et al.22 where the WrC was positively associated with such
cardio-metabolic risk factors as waist circumference, BMI, and
LDL-C, but inversely associated with HDL-C. Capizzi et al.25 also
found a close relationship between WrC, its bone component, andrist circumference for predicting the presence of coronary artery
i.org/10.1016/j.ihj.2016.10.011
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cents. More importantly, there were some other interesting
results: WrC was only independent factor to explain the variance
of triglyceride levels among children; in fact, WrC was a better
predictor than BMI for insulin resistance measures and for
triglyceride levels in overweight/obese children and adolescents.25
In a study by Aykan et al.,26 WrC and patients’ occupation were
reported as independent predictors of radial artery diameter which
is important for transradial approach for coronary angiography.
They found those patients with higher WrC or active outdoor job
(compared to ofﬁce workers) have higher radial artery diameter.
Unfortunately, in the present study we did not ask about the
participants’ occupation.
Those recent studies, along with the present investigation,
attract attention to WrC as a possible novel associated index for
developing dyslipidemia, obesity, or even insulin resistance,
opening new perspectives for better understanding of CVDs. Point
measurement of WrC and small number of the control subjects
might be considered as limitations of this study. We also think
ethnical differences might have a role and could be considered as a
possible confounder for the association between the WrC and CAD.
Moreover, by applying more quantitative measures for evaluation
of CAD, more exact results might be achieved. In this regard, Aykan
et al.27 recently used the Syntax score for grading the complexity of
CAD and found a moderate correlation between the METs score
and the Syntax score. Novel imaging modalities such as
intravascular ultrasonography could also be used for better
quantiﬁcation of the amount of atheromatous coronary artery
plaques. Finally, the study population is composed of relatively
young patients, and we did not employ risk stratiﬁcation by using
any cardiovascular risk scoring system. Inclusion of older patients
with higher risk scores may have yielded different results. Those
issues might be addressed in further studies.
5. Conclusion
In conclusion, WrC as a novel anthropometric parameter is
positively associated with level of serum triglyceride and
cholesterol and negatively associated with HDL-C level. However,
it cannot directly predict increased risk of CVDs. The association
between WrC and CAD risk may be signiﬁcant in some especial
demographic and racial subgroups which requires more investiga-
tions.
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